Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis. - Daum AK; Schlicker L; Schneider MA; Muley T; Klingmüller U; Schulze A; Thomas M; Christopoulos P; Sültmann H (Cancer & metabolism, 2025)